Cargando…
A microparticulate based formulation to protect therapeutic enzymes from proteolytic digestion: phenylalanine ammonia lyase as case study
Phenylketonuria is a genetic disorder affecting the metabolism of phenylalanine (phe) due to a deficiency in the enzyme phenylalanine hydroxylase. This disorder is characterized by an elevated phe blood level, which can lead to severe intellectual disabilities in newborns. The current strategy to pr...
Autores principales: | Pereira de Sousa, Irene, Gourmel, Charlotte, Berkovska, Olena, Burger, Michael, Leroux, Jean-Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046617/ https://www.ncbi.nlm.nih.gov/pubmed/32107425 http://dx.doi.org/10.1038/s41598-020-60463-y |
Ejemplares similares
-
Fluorescent enzyme-coupled activity assay for phenylalanine ammonia-lyases
por: Moisă, Mădălina E., et al.
Publicado: (2020) -
Fungal and Plant Phenylalanine Ammonia-lyase
por: Hyun, Min Woo, et al.
Publicado: (2011) -
Zymophore identification enables the discovery of novel phenylalanine ammonia lyase enzymes
por: Weise, Nicholas J., et al.
Publicado: (2017) -
Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
por: Bell, Sean M., et al.
Publicado: (2017) -
Genomic Characterization of Phenylalanine Ammonia Lyase Gene in Buckwheat
por: Thiyagarajan, Karthikeyan, et al.
Publicado: (2016)